Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Axogen Q3 Adj. EPS $0.12 Beats $0.07 Estimate, Sales $60.082M Beat $56.806M Estimate

Author: Benzinga Newsdesk | October 29, 2025 06:01am
Axogen (NASDAQ:AXGN) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.07 by 66.67 percent. This is a 71.43 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $60.082 million which beat the analyst consensus estimate of $56.806 million by 5.77 percent. This is a 23.51 percent increase over sales of $48.644 million the same period last year.

Posted In: AXGN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist